ATE45673T1 - Depot-antiphlogistika. - Google Patents

Depot-antiphlogistika.

Info

Publication number
ATE45673T1
ATE45673T1 AT84107267T AT84107267T ATE45673T1 AT E45673 T1 ATE45673 T1 AT E45673T1 AT 84107267 T AT84107267 T AT 84107267T AT 84107267 T AT84107267 T AT 84107267T AT E45673 T1 ATE45673 T1 AT E45673T1
Authority
AT
Austria
Prior art keywords
depot
antiphlogistics
alcohols
glycerides
amides
Prior art date
Application number
AT84107267T
Other languages
German (de)
English (en)
Inventor
Hans-Dieter Dr Dell
Bernhard Dr Pelster
Reinhold Kraus
Detlef Dr Schierstedt
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Application granted granted Critical
Publication of ATE45673T1 publication Critical patent/ATE45673T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Organic Insulating Materials (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Reinforced Plastic Materials (AREA)
AT84107267T 1983-07-05 1984-06-25 Depot-antiphlogistika. ATE45673T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833324192 DE3324192A1 (de) 1983-07-05 1983-07-05 Depot-antiphlogistika
EP84107267A EP0130524B1 (de) 1983-07-05 1984-06-25 Depot-Antiphlogistika

Publications (1)

Publication Number Publication Date
ATE45673T1 true ATE45673T1 (de) 1989-09-15

Family

ID=6203192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84107267T ATE45673T1 (de) 1983-07-05 1984-06-25 Depot-antiphlogistika.

Country Status (10)

Country Link
US (1) US4594357A (OSRAM)
EP (1) EP0130524B1 (OSRAM)
JP (1) JPH0647534B2 (OSRAM)
KR (1) KR910010019B1 (OSRAM)
AT (1) ATE45673T1 (OSRAM)
DE (2) DE3324192A1 (OSRAM)
DK (1) DK165441C (OSRAM)
ES (4) ES8600932A1 (OSRAM)
GR (1) GR82116B (OSRAM)
PT (1) PT78837B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3726797A1 (de) * 1987-08-12 1989-02-23 Bayer Ag Arzneimittel fuer den bereich der mundhoehle
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition
WO1998027963A2 (en) * 1996-12-20 1998-07-02 Alza Corporation Gel composition and methods
AU752552C (en) * 1997-09-30 2003-09-11 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DK1838716T3 (da) * 2005-01-05 2011-07-25 Lilly Co Eli Olanzapinpamota-dihydrat
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
BRPI1011188B1 (pt) 2009-05-06 2019-10-15 Laboratory Skin Care, Inc. Composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3590039A (en) * 1967-12-20 1971-06-29 Geigy Chem Corp N - (alpha,alpha,alpha,alpha',alpha',alpha' -hexafluoro - 3,5 - xylyl) anthranilic acid and salts thereof
US3673243A (en) * 1968-05-08 1972-06-27 Sumitomo Chemical Co Novel process for producing o-anilinophenylaliphatic acid derivatives
US3678094A (en) * 1970-04-20 1972-07-18 Merck & Co Inc Substituted anilino carboxylic acids
JPS474775U (OSRAM) * 1971-02-04 1972-09-12
US3778470A (en) * 1972-08-23 1973-12-11 A Sallman Chemical intermediates for the production of substituted 2-anilinophenylacetic acids and esters
JPS5314606A (en) * 1976-07-27 1978-02-09 Kawasaki Steel Co Good hydrogen brittleness resistance line pipe steel
JPS5337857A (en) * 1976-09-20 1978-04-07 Matsushita Electric Industrial Co Ltd Composite hybrid integrated circuit
US4307113A (en) * 1978-04-20 1981-12-22 Sandoz, Inc. Anthranilic acid derivatives
JPS5562049A (en) * 1978-10-31 1980-05-10 Bago Sa Labor Novel ester of phenyll and pyridinee33carboxylic acid and its manufacture
US4325949A (en) * 1980-02-15 1982-04-20 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤

Also Published As

Publication number Publication date
ES542318A0 (es) 1985-12-16
EP0130524A2 (de) 1985-01-09
ES8603266A1 (es) 1985-12-16
EP0130524A3 (en) 1986-08-13
ES542316A0 (es) 1985-12-16
ES542317A0 (es) 1986-04-16
ES8603267A1 (es) 1985-12-16
KR850000977A (ko) 1985-03-14
DK165441C (da) 1993-04-19
ES8605984A1 (es) 1986-04-16
EP0130524B1 (de) 1989-08-23
JPH0647534B2 (ja) 1994-06-22
DK328684A (da) 1985-01-06
DE3479478D1 (en) 1989-09-28
US4594357A (en) 1986-06-10
JPS6036408A (ja) 1985-02-25
DK328684D0 (da) 1984-07-04
ES533848A0 (es) 1985-10-16
GR82116B (OSRAM) 1984-12-13
ES8600932A1 (es) 1985-10-16
DE3324192A1 (de) 1985-01-17
DK165441B (da) 1992-11-30
PT78837B (en) 1986-06-02
PT78837A (en) 1984-08-01
KR910010019B1 (ko) 1991-12-10

Similar Documents

Publication Publication Date Title
ATE45673T1 (de) Depot-antiphlogistika.
IT7927250A0 (it) Composizione a base di magnesio per l'immagazzinamento di idrogeno eprocedimento per la preparazione di tale composizione.
DE69523951D1 (de) Stabilisierung der prostaglandinzusammensetzungen
IT1129802B (it) Agente antitumorale
IT1114631B (it) Compressa detergente per protesi dentarie o simili e procedimento per la produzione di essa
SE7709328L (sv) Rontgenkontrastmedel
AU536920B2 (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
ES8403472A1 (es) Procedimiento para la obtencion de un medio para combatir las pestes a base de como minimo de aminocetal.
GR69296B (OSRAM)
IT1131988B (it) Procedimento per migliorare la proprieta' di leghe
BG31473A3 (en) Fungicide means and method for fungus fighting
FI822099A0 (fi) Maettade aminocyklitderivat, deras framstaellning och dessa innehaollande laekemedel
IT8222392A0 (it) Procedimento per la produzione di attivatore plasminogeno.
SE8104538L (sv) 1-klor-1-p-metoxibensoylformaldoxim-n-metylkarbamat
IT1096161B (it) Indolo-diidroindolo dimerico,utile quale agente anti-tumorale
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
IT1075589B (it) Procedimento per la produzione di composizioni ad enzimi fissati
FR2319709A1 (fr) Milieu, notamment pour la constitution de milieux de culture de micro-organismes
ES1028955U (es) Auriculares.
BG38335A3 (en) Method for preparing 1- etoxycarbonyloxyethylic ester of penicillin g
UA13708A1 (uk) Кріопротектор
IT1255639B (it) Uso dell'oxatomide come agente antitosse
AR230551Q (es) Composicion insecticida que contiene como agente activaciones trans-crisantemos
ATE21381T1 (de) Stabilisierte zusammensetzungen von 1,1,1trichlor|than.
IT8124289A0 (it) Stabilizzazione di soluzioni di perossido di idrogeno.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee